Shaun Bagai

CIK: 0001862613

Transaction Breakdown

Open Market Buys (P)8 (72.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (27.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RNXT

RenovoRx, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

RNXT
RenovoRx, Inc.
Apr 3, 2026
Award(A)
Stock Option
Direct
946.1K shares-
RNXT
RenovoRx, Inc.
Mar 20, 2026
Purchase(P)
Indirect
24.3K shares-
RNXT
RenovoRx, Inc.
Dec 18, 2025
Purchase(P)
Direct
5K shares at avg. $0.90$5K
RNXT
RenovoRx, Inc.
Dec 17, 2025
Purchase(P)
Direct
5K shares at avg. $0.85$4K
RNXT
RenovoRx, Inc.
Aug 25, 2025
Purchase(P)
Direct
5K shares at avg. $0.91$5K
RNXT
RenovoRx, Inc.
Aug 22, 2025
Purchase(P)
Direct
5K shares at avg. $0.95$5K
RNXT
RenovoRx, Inc.
Jul 1, 2025
Award(A)
Stock Option
Direct
102.5K shares-
RNXT
RenovoRx, Inc.
Apr 15, 2025
Purchase(P)
Direct
7.5K shares at avg. $0.91$7K
RNXT
RenovoRx, Inc.
Apr 14, 2025
Award(A)
Stock Option
Direct
410K shares-
RNXT
RenovoRx, Inc.
Apr 9, 2025
Purchase(P)
Direct
10K shares at avg. $0.83$8K
RNXT
RenovoRx, Inc.
Apr 7, 2025
Purchase(P)
Direct
10K shares at avg. $0.83$8K

		Type	Shares	Price		Ownership
Apr 3, 2026	RNXT RenovoRx, Inc.	Award(A) Stock Option	946,107	-	-	Direct
Mar 20, 2026	RNXT RenovoRx, Inc.	Purchase(P)	24,300	-	$0	Indirect
Dec 18, 2025	RNXT RenovoRx, Inc.	Purchase(P)	5,000	$0.90	$4,507	Direct
Dec 17, 2025	RNXT RenovoRx, Inc.	Purchase(P)	5,000	$0.85	$4,262	Direct
Aug 25, 2025	RNXT RenovoRx, Inc.	Purchase(P)	5,000	$0.91	$4,549	Direct
Aug 22, 2025	RNXT RenovoRx, Inc.	Purchase(P)	5,000	$0.95	$4,748	Direct
Jul 1, 2025	RNXT RenovoRx, Inc.	Award(A) Stock Option	102,498	-	-	Direct
Apr 15, 2025	RNXT RenovoRx, Inc.	Purchase(P)	7,500	$0.91	$6,821	Direct
Apr 14, 2025	RNXT RenovoRx, Inc.	Award(A) Stock Option	409,992	-	-	Direct
Apr 9, 2025	RNXT RenovoRx, Inc.	Purchase(P)	10,000	$0.83	$8,300	Direct
Apr 7, 2025	RNXT RenovoRx, Inc.	Purchase(P)	10,000	$0.83	$8,300	Direct

1-11 of 11 transactions

About Bagai Shaun

Bagai Shaun (SEC CIK 0001862613) files insider reports with the SEC as Chief Executive Officer of RenovoRx, Inc. (RNXT).

Signal8 holds 10 ownership filings by Bagai Shaun, all Form 4s, filed between Apr 8, 2025 and Apr 7, 2026. Those filings report 11 transactions, from Apr 7, 2025 to Apr 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bagai Shaun's filings is in MOUNTAIN VIEW, CA.

Recent filings by Bagai Shaun

Apr 3, 2026: Grant or award of RNXT derivative securities (Form 4, code A).
Mar 20, 2026: Open-market purchase of RNXT shares (Form 4, code P).
Dec 18, 2025: Open-market purchase of RNXT shares (Form 4, code P).
Dec 17, 2025: Open-market purchase of RNXT shares (Form 4, code P).
Aug 25, 2025: Open-market purchase of RNXT shares (Form 4, code P).

Other insiders filing for RenovoRx, Inc. (RNXT)

Macfarlane K. Angela, Director
Spiegel Robert J., Director
RYAN UNA S, Director
Marton Laurence, Director
VOLL MARK, Chief Financial Officer
Gentry Leesa, Chief Clinical Officer

How to read Form 4 transaction codes